High-dose 131I-metaiodobenzylguanidine therapy in patients with high-risk neuroblastoma in Japan

被引:0
|
作者
Daiki Kayano
Hiroshi Wakabayashi
Kenichi Nakajima
Rie Kuroda
Satoru Watanabe
Anri Inaki
Ayane Toratani
Norihito Akatani
Takafumi Yamase
Yuji Kunita
Tomo Hiromasa
Aki Takata
Hiroshi Mori
Shintaro Saito
Raita Araki
Junichi Taki
Seigo Kinuya
机构
[1] Kanazawa University,Department of Nuclear Medicine, Kanazawa University Hospital and Department of Nuclear Medicine, Institute of Medical, Pharmaceutical and Health Science
[2] Kanazawa University,Department of Functional Imaging and Artificial Intelligence
[3] Kanazawa University,Department of Pediatrics, Kanazawa University Hospital and Department of Pediatrics, Institute of Medical, Pharmaceutical and Health Science
[4] Kanazawa Medical University,Department of Radiology
[5] Ishikawa Prefectural Central Hospital,Department of Pediatrics
来源
关键词
I-metaiodobenzylguanidine; Refractory neuroblastoma; Relapsed neuroblastoma; Internal radiation therapy; Radionuclide therapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:397 / 406
页数:9
相关论文
共 50 条
  • [31] Impact of Whole-Body Radiation Dose on Response and Toxicity in Patients With Neuroblastoma After Therapy With 131I-Metaiodobenzylguanidine (MIBG)
    Trieu, Megan
    DuBois, Steven G.
    Pon, Elizabeth
    Nardo, Lorenzo
    Hawkins, Randall A.
    Marachelian, Araz
    Twist, Clare J.
    Park, Julie R.
    Matthay, Katherine K.
    PEDIATRIC BLOOD & CANCER, 2016, 63 (03) : 436 - 442
  • [32] Tandem high-dose therapy in rapid sequence for children with high-risk neuroblastoma
    Grupp, SA
    Stern, JW
    Bunin, N
    Nancarrow, C
    Ross, AA
    Mogul, M
    Adams, R
    Grier, HE
    Gorlin, JB
    Shamberger, R
    Marcus, K
    Neuberg, D
    Weinstein, HJ
    Diller, L
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (13) : 2567 - 2575
  • [33] Radiation Exposure to Family Caregivers and Nurses of Pediatric Neuroblastoma Patients Receiving 131I-Metaiodobenzylguanidine (131I-MIBG) Therapy
    Markelewicz, Robert J., Jr.
    Lorenzen, William A.
    Shusterman, Suzanne
    Grant, Frederick D.
    Fahey, Frederic H.
    Treves, S. Ted
    CLINICAL NUCLEAR MEDICINE, 2013, 38 (08) : 604 - 607
  • [34] Feasibility and Efficacy of Treatment Strategy of Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation with Incorporation of High-Dose 131I-MIBG Therapy for High-Risk Neuroblastoma
    Shin, J.
    Koh, K. N.
    Suh, J. K.
    Min, S.
    Kim, Y. S.
    Namgoon, J. M.
    Kim, D. Y.
    Ahn, S. D.
    Kim, H.
    Im, H. J.
    Seo, J. J.
    Kook, H.
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S340 - S340
  • [35] Feasibility of Administering High-Dose 131I-MIBG Therapy to Children with High-Risk Neuroblastoma Without Lead-Lined Rooms
    Chu, Bae P.
    Horan, Christopher
    Basu, Ellen
    Dauer, Lawrence
    Williamson, Matthew
    Carrasquillo, Jorge A.
    Pandit-Taskar, Neeta
    Modak, Shakeel
    PEDIATRIC BLOOD & CANCER, 2016, 63 (05) : 801 - 807
  • [36] Phase I Study of Vincristine, Irinotecan, and 131I-Metaiodobenzylguanidine for Patients with Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial
    DuBois, Steven G.
    Chesler, Louis
    Groshen, Susan
    Hawkins, Randall
    Goodarzian, Fariba
    Shimada, Hiroyuki
    Yanik, Greg
    Tagen, Michael
    Stewart, Clinton
    Mosse, Yael P.
    Maris, John M.
    Tsao-Wei, Denice
    Marachelian, Araz
    Villablanca, Judith G.
    Matthay, Katherine K.
    CLINICAL CANCER RESEARCH, 2012, 18 (09) : 2679 - 2686
  • [37] Different outcomes for relapsed versus refractory neuroblastoma after therapy with 131I-metaiodobenzylguanidine (131I-MIBG)
    Zhou, Margaret J.
    Doral, Michelle Y.
    DuBois, Steven G.
    Villablanca, Judith G.
    Yanik, Gregory A.
    Matthay, Katherine K.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 (16) : 2465 - 2472
  • [38] Phase II Study of High-Dose [131I]Metaiodobenzylguanidine Therapy for Patients With Metastatic Pheochromocytoma and Paraganglioma
    Gonias, Sara
    Goldsby, Robert
    Matthay, Katherine K.
    Hawkins, Randall
    Price, David
    Huberty, John
    Damon, Lloyd
    Linker, Charles
    Sznewajs, Aimee
    Shiboski, Steve
    Fitzgerald, Paul
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (25) : 4162 - 4168
  • [39] Acute changes in blood pressure in patients with neuroblastoma treated with 131I-metaiodobenzylguanidine (MIBG)
    Wong, Thalia
    Matthay, Katherine K.
    Boscardin, W. John
    Hawkins, Randall A.
    Brakeman, Paul R.
    DuBois, Steven G.
    PEDIATRIC BLOOD & CANCER, 2013, 60 (09) : 1424 - 1430
  • [40] 131I-Metaiodobenzylguanidine Theranostics in Neuroblastoma: Historical Perspectives; Practical Applications
    Parisi, Marguerite T.
    Eslamy, Hedieh
    Park, Julie R.
    Shulkin, Barry L.
    Yanik, Gregory A.
    SEMINARS IN NUCLEAR MEDICINE, 2016, 46 (03) : 184 - 202